Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swiss (SMI) Healthcare Sector Analysis

UpdatedNov 09, 2025
DataAggregated Company Financials
Companies34
  • 7D1.2%
  • 3M4.2%
  • 1Y2.6%
  • YTD5.8%

In the last week, the Healthcare industry is up 1.2%, with Roche Holding up 3.7%. The industry has been flat over the past 12 months despite the gain this week. Looking forward, earnings are forecast to grow by 14% annually.

Sector Valuation and Performance

Has the Swiss Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 09 Nov 2025CHF 609.7bCHF 155.2bCHF 24.9b28.5x24.5x3.9x
Tue, 07 Oct 2025CHF 639.8bCHF 153.5bCHF 24.2b32.9x26.5x4.2x
Thu, 04 Sep 2025CHF 621.6bCHF 154.1bCHF 24.3b33.1x25.6x4x
Sat, 02 Aug 2025CHF 597.1bCHF 153.8bCHF 24.3b30.5x24.6x3.9x
Mon, 30 Jun 2025CHF 587.5bCHF 150.0bCHF 22.2b30.4x26.4x3.9x
Wed, 28 May 2025CHF 579.4bCHF 152.1bCHF 22.6b31.9x25.6x3.8x
Fri, 25 Apr 2025CHF 562.5bCHF 150.7bCHF 21.9b27.1x25.7x3.7x
Sun, 23 Mar 2025CHF 631.1bCHF 155.1bCHF 22.5b31.1x28x4.1x
Tue, 18 Feb 2025CHF 630.1bCHF 155.6bCHF 22.3b29.9x28.3x4x
Thu, 16 Jan 2025CHF 587.9bCHF 153.2bCHF 24.6b30.5x23.9x3.8x
Sat, 14 Dec 2024CHF 563.5bCHF 151.7bCHF 24.4b28.6x23.1x3.7x
Mon, 11 Nov 2024CHF 589.6bCHF 150.2bCHF 24.1b29.8x24.4x3.9x
Wed, 09 Oct 2024CHF 601.6bCHF 148.0bCHF 22.5b32.6x26.8x4.1x
Fri, 06 Sep 2024CHF 610.2bCHF 146.9bCHF 22.3b32.8x27.4x4.2x
Sun, 04 Aug 2024CHF 604.7bCHF 147.5bCHF 22.3b30.9x27.1x4.1x
Tue, 02 Jul 2024CHF 577.4bCHF 149.4bCHF 22.8b35.9x25.3x3.9x
Thu, 30 May 2024CHF 549.1bCHF 150.2bCHF 22.9b33.3x24x3.7x
Sat, 27 Apr 2024CHF 537.3bCHF 146.2bCHF 22.8b35.3x23.5x3.7x
Mon, 25 Mar 2024CHF 534.6bCHF 144.2bCHF 22.2b37.5x24x3.7x
Wed, 21 Feb 2024CHF 528.2bCHF 142.8bCHF 22.4b32.5x23.6x3.7x
Fri, 19 Jan 2024CHF 541.3bCHF 152.6bCHF 21.9b27.3x24.7x3.5x
Sun, 17 Dec 2023CHF 522.0bCHF 152.7bCHF 21.9b27.2x23.8x3.4x
Tue, 14 Nov 2023CHF 506.0bCHF 154.9bCHF 22.2b23.7x22.8x3.3x
Thu, 12 Oct 2023CHF 540.2bCHF 154.0bCHF 21.7b28.4x24.9x3.5x
Sat, 09 Sep 2023CHF 538.2bCHF 144.7bCHF 21.2b29.4x25.4x3.7x
Mon, 07 Aug 2023CHF 549.4bCHF 143.3bCHF 21.1b35.3x26x3.8x
Wed, 05 Jul 2023CHF 562.6bCHF 147.2bCHF 22.2b35.5x25.3x3.8x
Fri, 02 Jun 2023CHF 575.7bCHF 147.9bCHF 22.3b35.2x25.8x3.9x
Sun, 30 Apr 2023CHF 573.3bCHF 146.9bCHF 22.3b32.1x25.7x3.9x
Tue, 28 Mar 2023CHF 542.7bCHF 147.4bCHF 22.2b42.3x24.5x3.7x
Thu, 23 Feb 2023CHF 550.4bCHF 148.3bCHF 22.8b34.9x24.2x3.7x
Sat, 21 Jan 2023CHF 567.8bCHF 148.3bCHF 38.0b31.5x14.9x3.8x
Mon, 19 Dec 2022CHF 565.9bCHF 149.0bCHF 38.2b30.4x14.8x3.8x
Wed, 16 Nov 2022CHF 574.6bCHF 149.4bCHF 38.4b32.9x15x3.8x
Price to Earnings Ratio

15x


Total Market Cap: CHF 574.6bTotal Earnings: CHF 38.4bTotal Revenue: CHF 149.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Healthcare Sector Price to Earnings3Y Average 24.4x202320242025
Current Industry PE
  • Investors are relatively neutral on the Swiss Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 24.4x.
  • The industry is trading close to its 3-year average PS ratio of 3.8x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 13% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swiss Healthcare sector?

CH Market-0.24%
Healthcare1.16%
Healthtech3.35%
Pharma2.48%
Healthcare Services-1.23%
Medical Equipment-2.80%
Life Sciences-5.31%
Biotech-5.93%
Industry PE
  • Investors are most optimistic about the Healthtech industry which is trading above its 3-year average PE ratio of 24.5x.
    • Analysts are expecting annual earnings growth of 40.4%, which is higher than its past year's earnings decline of 80.3% per year.
Forecasted Growth
  • Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 40% over the next 5 years.
  • This is better than its past earnings decline of 80% per year.
  • In contrast, the Healthcare Services industry is expected to see its earnings grow by 5.3% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ROG Roche HoldingCHF 268.403.7%
+CHF 8.1b		2.0%PE24.2x
NOVN NovartisCHF 102.002.8%
+CHF 5.2b		9.8%PE16.9x
MOLN Molecular PartnersCHF 3.2913.3%
+CHF 14.4m		-40.5%PB1.3x
BIOV BioVersysCHF 26.4010.0%
+CHF 14.0m		n/aPS117.9x
ASCN Ascom HoldingCHF 3.703.4%
+CHF 4.3m		-18.9%PE44.3x

Latest News

NOVN
CHF 102.00
Novartis
7D
2.8%
1Y
9.8%

We Think Novartis' (VTX:NOVN) Robust Earnings Are Conservative

Nov 09
We Think Novartis' (VTX:NOVN) Robust Earnings Are Conservative
MOVE
CHF 140.20
Medacta Group
7D
-5.8%
1Y
25.2%

Medacta Group (VTX:MOVE) Is Looking To Continue Growing Its Returns On Capital

Nov 08
Medacta Group (VTX:MOVE) Is Looking To Continue Growing Its Returns On Capital
BIOV
CHF 26.40
BioVersys
7D
10.0%
1Y
n/a
GALD
CHF 143.70
Galderma Group
7D
-3.2%
1Y
72.3%
ROG
CHF 268.40
Roche Holding
7D
3.7%
1Y
2.0%
STMN
CHF 96.58
Straumann Holding
7D
-4.4%
1Y
-14.5%

STMN: Future Performance Will Depend On U S Operational Recovery And Margin Stability

Straumann Holding's analyst price target saw a modest decrease to CHF 111.29 from CHF 111.58, as analysts weighed improving U.S. operational trends in contrast with ongoing concerns over slower revenue growth and margin adjustments. Analyst Commentary Analysts remain divided on the outlook for Straumann Holding, highlighting both areas of growing confidence and lingering concerns regarding the company's performance and prospects.
SOON
CHF 211.30
Sonova Holding
7D
-3.3%
1Y
-34.7%

SOON: Market Resilience Will Be Tested By Rising Competition And End Market Weakness

Analysts have lowered their average price target for Sonova Holding from CHF 246.65 to CHF 242.47. This reflects a more cautious outlook amid concerns over softer end markets and increased competition.
ALC
CHF 59.02
Alcon
7D
-1.3%
1Y
-27.2%

Cutting Edge Eye Care Solutions Will Transform Outcomes For Global Aging Populations

Alcon's analyst price target has been revised slightly downward, decreasing by $1.25 to $79.17. Analysts have adjusted their expectations to reflect slightly lower revenue growth and profit margin forecasts.
SDZ
CHF 52.88
Sandoz Group
7D
-1.2%
1Y
31.7%

Future Opportunities Will Be Unlocked Through Expanding Pipeline And Global Market Reach

The analyst consensus price target for Sandoz Group rose modestly, increasing from CHF 50.20 to CHF 50.33. Analysts cited stronger revenue growth and improving profit margins in their updated outlooks.
BANB
CHF 50.95
Bachem Holding
7D
-12.5%
1Y
-32.8%

Bachem Holding AG's (VTX:BANB) Price In Tune With Earnings

Oct 25
Bachem Holding AG's (VTX:BANB) Price In Tune With Earnings
LONN
CHF 530.40
Lonza Group
7D
-4.3%
1Y
-3.4%
ASCN
CHF 3.70
Ascom Holding
7D
3.4%
1Y
-18.9%

Ascom Holding AG's (VTX:ASCN) Share Price Is Matching Sentiment Around Its Revenues

Sep 25
Ascom Holding AG's (VTX:ASCN) Share Price Is Matching Sentiment Around Its Revenues
MOLN
CHF 3.29
Molecular Partners
7D
13.3%
1Y
-40.5%